Michael P. Stehn
Corporate Officer/Principal at Parenteral Drug Association
Profile
Michael P.
Stehn is a Member of the Parenteral Drug Association.
He was previously the Director of Quality Assurance & Regulatory Compliance at The Rugby Group, Inc. and the Senior Vice President of Operations at Akorn, Inc. from 1990 to 2020.
He obtained an undergraduate degree from Fairleigh Dickinson University.
Currently, Mr. Stehn holds a job at Parenteral Drug Association.
Michael P. Stehn active positions
| Companies | Position | Start |
|---|---|---|
| Parenteral Drug Association | Corporate Officer/Principal | - |
Former positions of Michael P. Stehn
| Companies | Position | End |
|---|---|---|
| AKORN, INC. | Chief Operating Officer | 04/09/2012 |
The Rugby Group, Inc.
 The Rugby Group, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., The Rugby Group, Inc. is a company that develops and manufactures generic drugs. The company is based in Parsippany, NJ. The Rugby Group was acquired by Actavis, Inc. from Hoechst AG on August 26, 1997 for $70 million. | Corporate Officer/Principal | - |
Training of Michael P. Stehn
| Fairleigh Dickinson University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Akorn, Inc.
 Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL. | Health Technology |
The Rugby Group, Inc.
The Rugby Group, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., The Rugby Group, Inc. is a company that develops and manufactures generic drugs. The company is based in Parsippany, NJ. The Rugby Group was acquired by Actavis, Inc. from Hoechst AG on August 26, 1997 for $70 million. | Health Technology |
| Parenteral Drug Association |
- Stock Market
- Insiders
- Michael P. Stehn
